Biopurification of monoclonal antibody (mAb) through crystallisation
Therapeutics based on monoclonal antibody (mAb) represent one of the most advanced biopharmaceuticals, being able to treat a wide range of challenging diseases such as cancers and arthritis. As the scale of mAb production steadily increases with the demand for mAb-based therapeutics, the downstream...
| Published in: | Separation and Purification Technology |
|---|---|
| Main Author: | |
| Format: | Review |
| Language: | English |
| Published: |
Elsevier B.V.
2021
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100440810&doi=10.1016%2fj.seppur.2021.118358&partnerID=40&md5=07688f1b6a62ce55e9b813911484b879 |